Knight Therapeutics, Inc. (GUD.TO)
11.61
-0.09
(-0.77%)
CAD |
TSX |
Oct 23, 16:00
Knight Therapeutics Max Drawdown (5Y) : 52.84% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 52.84% |
| August 31, 2026 | 52.84% |
| July 31, 2026 | 53.39% |
| June 30, 2026 | 53.76% |
| May 31, 2026 | 53.76% |
| April 30, 2026 | 53.76% |
| March 31, 2026 | 53.76% |
| February 28, 2026 | 54.22% |
| January 31, 2026 | 54.22% |
| December 31, 2025 | 54.22% |
| November 30, 2025 | 54.22% |
| October 31, 2025 | 54.22% |
| September 30, 2025 | 54.22% |
| August 31, 2025 | 54.22% |
| July 31, 2025 | 54.22% |
| June 30, 2025 | 54.22% |
| May 31, 2025 | 54.22% |
| April 30, 2025 | 54.22% |
| March 31, 2025 | 54.22% |
| February 28, 2025 | 54.77% |
| January 31, 2025 | 54.77% |
| December 31, 2024 | 54.77% |
| November 30, 2024 | 54.77% |
| October 31, 2024 | 54.77% |
| September 30, 2024 | 54.77% |
| Date | Value |
|---|---|
| August 31, 2024 | 54.77% |
| July 31, 2024 | 54.77% |
| June 30, 2024 | 54.77% |
| May 31, 2024 | 54.77% |
| April 30, 2024 | 54.77% |
| March 31, 2024 | 54.77% |
| February 29, 2024 | 54.77% |
| January 31, 2024 | 95.02% |
| December 31, 2023 | 95.02% |
| November 30, 2023 | 95.02% |
| October 31, 2023 | 95.02% |
| September 30, 2023 | 95.02% |
| August 31, 2023 | 95.02% |
| July 31, 2023 | 95.02% |
| June 30, 2023 | 95.02% |
| May 31, 2023 | 95.02% |
| April 30, 2023 | 95.02% |
| March 31, 2023 | 95.02% |
| February 28, 2023 | 95.02% |
| January 31, 2023 | 95.09% |
| December 31, 2022 | 95.09% |
| November 30, 2022 | 95.09% |
| October 31, 2022 | 95.09% |
| September 30, 2022 | 95.09% |
| August 31, 2022 | 95.09% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| HLS Therapeutics, Inc. | 87.57% |
| Bausch Health Cos., Inc. | 87.23% |
| Cipher Pharmaceuticals, Inc. | 72.28% |
| BioSyent, Inc. | 37.15% |
| Revive Therapeutics Ltd. | 99.36% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 10.34 |
| Beta (5Y) | 0.0460 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 20.50% |
| Historical Sharpe Ratio (5Y) | 0.5291 |
| Historical Sortino (5Y) | 1.116 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 7.13% |